The Latest Studies, Therapeutic Developments in C difficile


New therapeutics have been FDA approved as well as real-world studies glean information about their efficacy.

Within this area of care, there are a number of ongoing studies looking at new therapies to treat and prevent Clostridioides difficile infection (CDI). In the last several months, there has also been FDA approved therapeutics to treat recurrent C diff.

Learn more about these investigational therapies as well as real-world studies for approved treatments.

Related Videos
© 2024 MJH Life Sciences

All rights reserved.